| Recipient | Amount | Discipline | Title |
| Prasad Devarajan, MD | $50,000 | Nephrology | CORE-CCHMC/UC Clinical Proteomics and Biofluid Profiling Core |
| Bradley Britigan, MD | $91,545 | UC--Internal Medicine | Oxidative Inactivation of B2-Agonists by Endogenous Peroxidases in the Asthmatic Airway |
| Robert Hinton, MD | $100,000 | Cardiology | Angiogenesis Inhibition Therapy for Aortic Valve Disease |
| Prabir Roy-Chaudhury, MD | $100,000 | UC--Nephrology | Biodegradable Metallic Stents to Enhance Arteriovenous Fistula Maturation |
| Noah Shroyer, PhD | $100,000 | Gastroenterology, Hepatology & Nutrition | Neointestine from Live Donors and Pluripotent Stem Cells |
| Michael Bennett, PhD | $100,000 | Nephrology | Biomarkers to Distinguish Classes of Lupus Nephritis |
| H. Leighton Grimes, PhD | $100,000 | Immunobiology | microRNA in Acute Myeloid Leukemia |
| Nira Ben-Jonathan, PhD | $100,000 | UC--Cancer & Cell Biology & IntMed | Metabolic Actions of Antipsychotics on Adipose Tissue Samples from Children and Adolescents |
| Susanne Wells, PhD | $75,000 | Hematology/Oncology | DEK-targeted Virotherapy in Human Cancers |
| Thomas Korfhagen, MD, PhD | $75,000 | Neonatology & Pulmonary Biology | Signaling Inhibitor Treatment of Pulmonary Fibrosis |
| Rohit Kohli, MD | $75,000 | Gastroenterology, Hepatology & Nutrition | ApoAI as a Novel Drug Target for the Metabolic Syndrome |
| Philip Howles, PhD | $25,000 | UC--Pathology & Lab Medicine | 2nd year - CEL Inhibitors for Treatment of Cardiovascular Disease |
| Gail Jean Pyne-Geithman, DPhil | $25,000 | UC--Neurosurgery | Novel Theranostic Test for Congenital CrT Deficiency |
| Ian Papautsky, PhD | $25,000 | UC--Electronics & Computing Systems | 2nd year - Zinc Chip for POC Monitoring in Critically Ill Children |
